ATAI News and Press, ATAI Life Sciences N.V. From 07/28/22

On July 13, 2022, two amendments passed in the House of Representatives that would provide psychedelic drug treatment to veterans and active duty service members. A documentary based on Michael Pollan's 2018 book, "How to Change Your Mind," is one of Netflix's most-watched shows. ...

Palm Beach, FL – July 27, 2022 – For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vietnam war and is still the preferred anesthetic in battlefield situations...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips State and federal governments have played a larger role when it comes to approving illegal substances. Most notably, cannabis stocks have been in focus over the last few years, as various government bodies have given mariju...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: rhendrikdwenz via Shutterstock So far, 2022 has been a rocky year for Cathie Wood’s exchange-traded funds (ETFs). Her flagship fund, the ARK Innovation ETF (NYSEARCA: ARKK ) is down more than 50% ye...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cathie Wood’s flagship fund, the ARK Innovation (NYSEARCA: ARKK ) exchange-traded fund (ETF), has lost over 50% since the year began. However, investors still seem to be confident in ARK Invest’s activ...

ATAI is backed by Peter Thiel. Its decentralized business model is pretty unique. I will wait for more data before I take a call on this very interesting company. Atai Life Sciences N.V. ( ATAI ) is a German-headquartered developer of medicines for mental health diso...

Tech stocks have crashed, but Wall Street should eventually remember why the love affair began in the first place. After the tech crash, it makes sense to invest in a large quantity of names. Even so, this isn't an excuse to buy anything and everything. Don’t waste your tim...

Kures Therapeutics, an atai Life Sciences ( NASDAQ: ATAI ) appoints of Chad E. Beyer, Ph.D., MBA,  as CEO of Kures succeeding Dr. Srinivas Rao, effective July 1, 2022. Dr. Srinivas Rao will continue to support and advise Kures’ pro...

NEW YORK, June 30, 2022 (GLOBE NEWSWIRE) -- Kures Therapeutics, Inc (“Kures”), an atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”) company focused on developing treatment options to better manage addictions, depression, and pain, today announced the appointment of...

The stock market has been tough over the last month, as has most of the U.S. economy. The Federal Reserve raised interest rates by 0.75 percent on Wednesday, June 15, and that reduces the amount of money in the economy. Besides mortgages, rising interest rates impact...